Common Contracts

EX-10.1 2 dex101.htm INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT CONFIDENTIAL TREATMENT REQUESTED WITH RESPECT TO CERTAIN PORTIONS HEREOF DENOTED WITH “***” INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT between QLT USA, INC. AND ARIUS TWO, INC.

Intellectual Property Assignment Agreement • May 5th, 2020 • New York

• Contract Type
  Intellectual Property Assignment Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT between QLT USA, INC. AND ARIUS TWO, INC.

Intellectual Property Assignment Agreement • August 9th, 2006 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

• Contract Type
  Intellectual Property Assignment Agreement
• Filed
  August 9th, 2006
• Company
  Biodelivery Sciences International Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Intellectual Property Assignment Agreement (the “Agreement“) is made as of August 2, 2006 (the “Effective Date“) by and between QLT USA, Inc. (formerly Atrix Laboratories, Inc.), a Delaware corporation with its principal office at 2579 Midpoint Drive, Fort Collins, CO 80525-4417 (“Seller“), and Arius Two, Inc., a Delaware corporation with a mailing address at P.O. Box 14601, Research Triangle Park, NC 27709 (“Buyer“). Seller and Buyer are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”